SCHEMBL7784820

SCHEMBL7784820

CCc1cc(Br)cc(N)c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.41
POLB P06746 2/20 0.41
GABRA1 P14867 1/20 0.34
GABRB2 P47870 1/20 0.34
ALDH1A1 P00352 4/20 0.34
MAPT P10636 2/20 0.34
CYP2D6 P10635 2/20 0.33
SLC6A4 P31645 2/20 0.33
KCNH2 Q12809 2/20 0.33
SIGMAR1 Q99720 2/20 0.33
ABCB11 O95342 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
AR P10275 1/20 0.33
SLC6A2 P23975 1/20 0.33
PDE4A P27815 1/20 0.33
SLC6A3 Q01959 1/20 0.33
LMNA P02545 3/20 0.33
CYP3A4 P08684 1/20 0.33
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL637010 0.88 HTT (0.50) HTTPOLBGABRA1GABRB2ALDH1A1
SCHEMBL8429788 0.82 CYP2D6 (0.47) HTTPOLBGABRA1GABRB2ALDH1A1
SCHEMBL31531584 0.82 CYP2D6 (0.47) HTTPOLBGABRA1GABRB2ALDH1A1
SCHEMBL1145124 0.80 ALDH1A1 (0.49) HTTPOLBGABRA1GABRB2ALDH1A1
SCHEMBL23115658 0.78 HTT (0.38) HTTPOLBGABRA1GABRB2ALDH1A1
SCHEMBL29617504 0.78 HTT (0.38) HTTPOLBGABRA1GABRB2ALDH1A1
SCHEMBL11141869 0.78 HTT (0.38) HTTPOLBGABRA1GABRB2ALDH1A1
SCHEMBL18398219 0.78 HTT (0.38) HTTPOLBGABRA1GABRB2ALDH1A1
SCHEMBL18152760 0.77 ABCB11 (0.31) HTTCYP2D6SLC6A4KCNH2SIGMAR1
SCHEMBL7032888 0.76 HTT (0.43) HTTPOLBGABRA1GABRB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177604-A1 HETEROCYCLIC KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-06-14 EP disclosed
WO-2017019828-A1 ARYL SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2017-02-02 WO disclosed
WO-2016022312-A1 HETEROCYCLIC KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-02-11 WO disclosed
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed
US-6147075-A ANALGESICS; PSYCHOLOGICAL DISORDERS COCENSYS, INC. (US) 2000-11-14 US disclosed
US-5977107-A Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists COCENSYS, INC. (US) 1999-11-02 US disclosed
US-5631373-A NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-05-20 US disclosed